BlackRock Inc. - VIRIOS THERAPEUTICS INC ownership

VIRIOS THERAPEUTICS INC's ticker is VIRI and the CUSIP is 92829J104. A total of 18 filers reported holding VIRIOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of VIRIOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$698
-33.0%
7550.0%0.00%
Q2 2023$1,042
-93.0%
755
-98.1%
0.00%
Q1 2023$14,918
+61.0%
40,594
+3.4%
0.00%
Q4 2022$9,263
-38.2%
39,250
+2.3%
0.00%
Q3 2022$15,000
-76.9%
38,354
+152.3%
0.00%
Q2 2022$65,000
-18.8%
15,199
-14.5%
0.00%
Q1 2022$80,000
-15.8%
17,768
-4.7%
0.00%
Q4 2021$95,000
+13.1%
18,641
+17.6%
0.00%
Q3 2021$84,000
+37.7%
15,856
+64.3%
0.00%
Q2 2021$61,000
+1425.0%
9,653
+1242.6%
0.00%
Q1 2021$4,0007190.00%
Other shareholders
VIRIOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
McCollum Christoferson Group LLC 33,300$30,7960.01%
&PARTNERS 11,000$10,1730.01%
Virtu Financial LLC 27,322$250.00%
XTX Topco Ltd 14,441$13,3550.00%
RAYMOND JAMES & ASSOCIATES 30,000$27,7440.00%
WELLS FARGO & COMPANY/MN 124$1150.00%
NORTHERN TRUST CORP 24,035$22,2280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 11,482$10,6190.00%
GEODE CAPITAL MANAGEMENT, LLC 174,469$161,3750.00%
View complete list of VIRIOS THERAPEUTICS INC shareholders